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Synthesis of novel sugar diamino acids 
Abstract 
Sugar amino acids (SAAs) are found in nature as good construction elements for the preparation of 
peptide mimetics and oiigosaccharides in drug design and development. The synthesis of SAAs is readily 
accomplished in few steps and more than 40 SAAs have been synthesised to date.2 Sugar amino acids 
with an additional amino group, the sugar diamino acid (SDAs) would represent a useful expansion to the 
library of SAAs available because one of the amino group and carboxylic acid is available for peptide 
coupling and the another amino/azide group allow to do further derivatisation via peptide or click 
chemistry such as labelling. However, the synthesis of SDAs is challenging and only three general type 
have been reported to date.2 As part of a project involving the synthesiso f novel integrin antagonists, we 
require a new series of SDAs to be developed. Herein, the synthesis of the novel SDAs type 1 and 2 and 
their applications will be presented. Reference: (1) Gruner, S. A.; Locardi, E.; Lohof, E.; Kessler, H. Chemical 
Reviews 2002, 102, 491-514. (2) Risseeuw, M. D. P.; Overhand, M.; Fleet,G . W J.; Simone. M. I. 
Tetrahedron: Asymmetry 2007, 18, 2001-2010. 
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Sugar amino acids (SAAs) are found in nature as good
construction elementsl for the preparation of peptide
mimetics and oiigosaccharides in drug design and
development. The synthesis of SAAs is readily
accomplished in few steps and more than 40 SAAs have
been synthesised to date.2 Sugar amino acids with an
additional amino group, the sugar diamino acid (SDAs)
would represent a useful expansion to the library of SAAs
available because one of the amino group and carboxylic
acid is available for peptide coupling and the another
amino/azide group allow to do further derivatisation via
peptide or click chemistry such as labelling. However, the
synthesis of SDAs is challenging and only three general
type have been reported to date.2 As part of a project
involving the synthesis of novel integrin antagonists, we
require a new series of SDAs to be developed. Herein, the
synthesis of the novel SDAs type 1 and 2 and their
applications will be presented.
translationally modifi ed by a glycosylphosphatidylinositol
(GPI) glycolipid rhat anchors the protein to rhe cell
membrane. The biosynthesis and attachment of GpI
precursors to proteins in the endoplasmic reticulum has
been well defined, whereas subsequent carbohydrate side_
chain modifications of protein_bound GpIs are still larselv
uncharacterized. N-acetylgalactosamine (GalNAc) fi;ked
to the first mannose of the core GpI glycan has been
previously reported to be heterogeneously present on
certain mammalian Gpl-anchored proteins. However,
nothing is known about the timing and mechanisms of
GalNAc addition, due in part to the lack of an eft-ective
method to visualize GalNAc-containing GpIs.
Here we present a method for proflling GalNAc_containing
GPIs in mammalian cells by metabolic labeling with
N-azidoacetylgalactosamine (GalNAz) followed by
Staudinger ligation to a biotinylated phosphine probe.
This approach was validated Uy CatNei labeling of
endogenous and recombinant Gpl_anchored proteins,
followed by methodical characterization of GpIs
containing the azide-activated sugar. GpI labeling with
GalNAz confirms the identity of the HexNAc residue
identified by mass spectrometry in GpI moieties of
analyzed mammalian cells. To our knowledge, this is the
flrst direct labeling of the GpI glycan with an azide_labeled
sugar. This method permits the detection of GpIs Dresent
in the cells under normal physiological conditions,
including GPI structures that are difficult to study using
conventional labeling techniques. The use of this method
for specific enrichment of GalNAc_containing GpIs and
GPl-anchored proteins will be discussed.
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Deoxygenation of D-glucose and D_mannose at C_2 leads
to structurally identical compounds known for historical
reasons as 2-deoxy-D-glucose (2_DG). 2_DG is a known
inhibitor of glycolysis and has been shown to interfere
with the metabolism of D-glucose. Because 2_DG is also a
2-deoxy-D-mannose, we would expect that it would also
interefere with mannose biosynthetic processes. Thus, we
hypothesized rhat the 2-DG-mediared inhibition of glioma-
derived stem cells (GSCll) grown under normoxic
conditions results from the ability of 2_DG to affect
D-glucose and D-mannose bioenergetic and biosynthetic
processes. In our approach we have used mass spectrometry
to analyze in detail the effects of 2_DG on the formation of
N--elycans and its abillity to substitute for D_mannose in
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Many eukaryotic cell surface proteins are posr_
